Barinthus Biotherapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Barinthus Biotherapeutics generated cash of -$50,925,000, which is less than the previous year. Cash used in financing activities reached the amount of $1,872,000 last year. Net change in cash is therefore -$52,295,000.
Cash Flow
| 2019 | -18.75M | 1.92M | 1 |
|---|---|---|---|
| 2020 | -11.02M | -293K | 41.43M |
| 2021 | -32.58M | -12.91M | 222.74M |
| 2022 | -14.43M | -5.75M | 325K |
| 2023 | -50.92M | -5.41M | 1.87M |
BRNS Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 194.38M | 214.05M | 43.26M | 11.43M | 28.26M |
Operating activities | |||||
Net income | -73.44M | 5.32M | -51.11M | -17.93M | -20.81M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 0 | 4.32M | 602K | 208K | 346.86K |
Stock-based compensation expense | 5.05M | 9.87M | 16.48M | 3.62M | 0 |
| Deferred income tax benefit | 5.05M | 9.87M | 16.48M | 3.62M | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 5.8M | -5.83M | 559K | 479K | -963.16K |
Inventories | 0 | -648K | -4.14M | 889K | -4 |
Accounts payable | -3.37M | 1.14M | -3.52M | 586K | 2.97M |
Cash generated by operating activities | -50.92M | -14.43M | -32.58M | -11.02M | -18.75M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -6.13M | -1.14M | -293K | -128.34K |
Acquisitions Net | 0 | 387.76K | -11.76M | 252.89K | 2.05M |
Cash generated by investing activities | -5.41M | -5.75M | -12.91M | -293K | 1.92M |
Financing activities | |||||
Common Stock Issued | 2.03M | 484K | 102.77M | 49 | 1 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -159K | 0 | -41.50M | 0 |
Cash used in financing activities | 1.87M | 325K | 222.74M | 41.43M | 1 |
Net Change In Cash | -52.29M | -19.66M | 170.78M | 31.83M | -16.83M |
Cash at end of period | 142.09M | 194.38M | 214.05M | 43.26M | 11.43M |
| Data source |